Celltrion
068270.KS
#829
Rank
C$38.68 B
Marketcap
C$172.03
Share price
0.38%
Change (1 day)
8.42%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): C$1.48

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$1.48. In 2023 the company made an earnings per share (EPS) of C$3.83 a decrease over its 2022 EPS that were of C$3.91.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$1.48
2023C$3.83-2.08%
2022C$3.91-11.72%
2021C$4.432.03%
2020C$4.3482.8%
2019C$2.3718.31%
2018C$2.01-36.33%
2017C$3.15161.25%
2016C$1.212.86%
2015C$1.1717.84%
2014C$0.995.87%
2013C$0.94-70.85%
2012C$3.22134.09%
2011C$1.3843.59%
2010C$0.9674.49%
2009C$0.55317.8%
2008C$0.13-71.7%
2007C$0.46